Upcoming Events

Current and future events


GAP-Net Site Optimization Conference 2022

Join us for a unique opportunity to bring together academic and private sites outside the realm of specific Alzheimer’s disease (AD) and Parkinson’s disease (PD) clinical trials. Meet and network with leadership from clinical trial sites across North America, global pharma sponsors, and many partners in AD and PD clinical trial development. Hear from world-class sites and partners on current development barriers, best practices and strategies and engage in the future of clinical trials.
Attending this conference gives you the opportunity to engage with representatives from research sites, to hear their experiences and feedback first-hand outside the scope of working with them directly on a clinical trial. Attendees may glean site perspectives, research trends, common study barriers and innovative solutions, and share how  sponsors can be more responsive to sites to increase success in recruitment and enrolment. We have received positive feedback from industry partners who have attended in the past regarding the value they gained in this “out of office” encounter opportunity.


CHDI - 17th Annual Huntington's Disease Therapeutics Conference

The conference will cover all aspects of HD drug development, including current and future biomarkers, novel HD therapeutic approaches, the new HD Integrated Staging System, updates on clinical trials including GENERATION HD1, and other presentations informing our understanding of HD pathophysiology.


AD/PD™ 2022​

AD/PD™ 2022​ brings a new look and a new chapter in the history of the AD/PD™ series of conferences. By merging together with the AAT-AD/PD™ Advances in Alzheimer’s Therapies Focus Meeting, AD/PD™ is now transformed into an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
We are excited to provide improved opportunities for international medical and scientific professionals to come together and discuss the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
A central theme of the 2022 conference will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.


AAIC 2022

Join us in San Diego and online for AAIC 2022, where the world’s leading basic scientists, clinical researchers, early career investigators, clinicians and the care research community will share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer’s disease.